Amanote Research
Register
Sign In
The Cost-Effectiveness of Four Chinese Patent Medicine in the Treatment of Angina Pectoris in China
Value in Health
- United Kingdom
doi 10.1016/j.jval.2014.08.261
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2014
Authors
L. Sun
S. Zhu
Y. Chen
C Wang
Publisher
Elsevier BV
Related search
Cost-Effectiveness of Ranolazine for the Treatment of Angina Pectoris in Russia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Treatment of Angina Pectoris
New England Journal of Medicine
Medicine
Nicotinic Acid in the Treatment of Angina Pectoris
Heart
Cardiovascular Medicine
Cardiology
The Operative Treatment of Angina Pectoris
BMJ
Treatment of Angina Pectoris
Japanese Circulation Journal
Surgical Treatment of Angina Pectoris
JAMA - Journal of the American Medical Association
Medicine
Ranolazine for the Symptomatic Treatment of Patients With Chronic Angina Pectoris in Greece: A Cost-Utility Study
BMC Health Services Research
Health Policy
Verapamil in Angina Pectoris.
British Journal of Clinical Pharmacology
Pharmacology
Angina Pectoris.
BMJ